Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis.
in-stent restenosis
intracranial atherosclerotic stenosis
meta-analysis
percutaneous transluminal angioplasty and stenting
risk factors
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
20
02
2023
accepted:
26
06
2023
medline:
31
7
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
In-stent restenosis (ISR) is an adverse and notable event in the treatment of intracranial atherosclerotic stenosis (ICAS) with percutaneous transluminal angioplasty and stenting (PTAS). The incidence and contributing factors have not been fully defined. This study was performed to evaluate factors associated with ISR after PTAS. We identified studies on ISR after PTAS from an electronic search of articles in PubMed, Ovid MEDLINE, and the Cochrane Central Database (dated up to July 2022). A total of 19 studies, including 452 cases of ISR after 2,047 PTAS, were included in the meta-analysis. The pooled incidence rate of in-stent restenosis was 22.08%. ISR was more likely to occur in patients with coronary artery disease (OR = 1.686; 95% CI: 1.242-2.288; The present study provides the current estimates of the robust effects of some risk factors for in-stent restenosis in intracranial atherosclerotic stenosis. The Enterprise stent had advantages compared with the Wingspan stent for ISR. The significant risk factors for ISR were coronary artery disease, dissection, and high residual stenosis. Local anesthesia was a suspected factor associated with ISR.
Sections du résumé
Background
UNASSIGNED
In-stent restenosis (ISR) is an adverse and notable event in the treatment of intracranial atherosclerotic stenosis (ICAS) with percutaneous transluminal angioplasty and stenting (PTAS). The incidence and contributing factors have not been fully defined. This study was performed to evaluate factors associated with ISR after PTAS.
Data source
UNASSIGNED
We identified studies on ISR after PTAS from an electronic search of articles in PubMed, Ovid MEDLINE, and the Cochrane Central Database (dated up to July 2022).
Results
UNASSIGNED
A total of 19 studies, including 452 cases of ISR after 2,047 PTAS, were included in the meta-analysis. The pooled incidence rate of in-stent restenosis was 22.08%. ISR was more likely to occur in patients with coronary artery disease (OR = 1.686; 95% CI: 1.242-2.288;
Conclusions
UNASSIGNED
The present study provides the current estimates of the robust effects of some risk factors for in-stent restenosis in intracranial atherosclerotic stenosis. The Enterprise stent had advantages compared with the Wingspan stent for ISR. The significant risk factors for ISR were coronary artery disease, dissection, and high residual stenosis. Local anesthesia was a suspected factor associated with ISR.
Identifiants
pubmed: 37521300
doi: 10.3389/fneur.2023.1170110
pmc: PMC10375724
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
1170110Informations de copyright
Copyright © 2023 Wang, Lu, Feng, Lin, Gao, Wu, Wang and Wan.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Ann Intern Med. 1997 Nov 1;127(9):820-6
pubmed: 9382404
Stroke. 2006 Oct;37(10):2562-6
pubmed: 16960090
Turk Neurosurg. 2016;26(1):69-76
pubmed: 26768871
Stroke. 2013 Jul;44(7):2000-3
pubmed: 23696549
Circulation. 2001 Apr 3;103(13):1740-5
pubmed: 11282904
Stroke Vasc Neurol. 2018 May 7;3(3):176-184
pubmed: 30294474
N Engl J Med. 2011 Sep 15;365(11):993-1003
pubmed: 21899409
J Neurointerv Surg. 2010 Jun;2(2):104-9
pubmed: 21990588
Neurology. 2007 Feb 6;68(6):420-6
pubmed: 17283316
J Int Med Res. 2013 Apr;41(2):265-75
pubmed: 23569022
Neurosurgery. 2013 May;72(5):777-95; discussion 795
pubmed: 23328689
J Neurosurg. 2021 Oct 29;136(6):1716-1725
pubmed: 34715652
Interv Neuroradiol. 2013 Sep;19(3):276-82
pubmed: 24070075
Sci Rep. 2021 May 18;11(1):10479
pubmed: 34006896
Neuroradiology. 2012 Jan;54(1):43-50
pubmed: 21221557
JAMA Neurol. 2022 Feb 1;79(2):176-184
pubmed: 34982098
Neurosurgery. 2012 Jan;70(1):91-101; discussion 101
pubmed: 21778921
Catheter Cardiovasc Interv. 2011 Aug 1;78(2):286-93
pubmed: 20824757
Neurology. 2007 Jun 12;68(24):2099-106
pubmed: 17409371
Neurosurgery. 2013 Apr;72(4):596-604; discussion 604
pubmed: 23277374
Stroke. 1995 Jan;26(1):14-20
pubmed: 7839388
Front Neurol. 2021 Jan 26;11:601199
pubmed: 33574792
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
ANZ J Surg. 2003 Sep;73(9):712-6
pubmed: 12956787
Stroke. 1996 Nov;27(11):1974-80
pubmed: 8898801
Sci Rep. 2021 Aug 2;11(1):15599
pubmed: 34341413
Am J Transl Res. 2021 Jun 15;13(6):7115-7123
pubmed: 34306471
Minim Invasive Neurosurg. 2011 Feb;54(1):21-8
pubmed: 21506064
Cardiovasc Intervent Radiol. 2012 Apr;35(2):268-78
pubmed: 21516376
N Engl J Med. 1999 Jan 14;340(2):115-26
pubmed: 9887164
AJNR Am J Neuroradiol. 1998 Sep;19(8):1463-9
pubmed: 9763379
AJNR Am J Neuroradiol. 2010 Apr;31(4):586-97
pubmed: 20133387
Plast Reconstr Surg. 2011 Jul;128(1):305-310
pubmed: 21701348
Stroke. 2013 Nov;44(11):2990-4
pubmed: 23963335
Arch Iran Med. 2016 May;19(5):317-22
pubmed: 27179162
Stroke. 2012 Feb;43(2):580-4
pubmed: 22246690
Eur J Vasc Endovasc Surg. 2010 Oct;40(4):499-506
pubmed: 20554461
BMC Neurol. 2015 Oct 08;15:187
pubmed: 26449986
J Aging Health. 2015 Aug;27(5):843-63
pubmed: 25649677
Neurosurgery. 2009 Jan;64(1):79-84; discussion 84-5
pubmed: 19050657
AJNR Am J Neuroradiol. 2008 Jan;29(1):23-7
pubmed: 17989366
Radiology. 1995 Feb;194(2):477-81
pubmed: 7824729
AJNR Am J Neuroradiol. 2012 Feb;33(2):343-7
pubmed: 22173759
AJNR Am J Neuroradiol. 2005 Aug;26(7):1751-6
pubmed: 16091525
AJNR Am J Neuroradiol. 2011 Aug;32(7):1221-6
pubmed: 21546459
Cardiovasc Intervent Radiol. 2011 Aug;34(4):744-50
pubmed: 20927521
Cardiovasc Intervent Radiol. 2011 Feb;34(1):54-60
pubmed: 20458585
J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C7-12
pubmed: 16631513
JAMA. 2006 Jan 11;295(2):180-9
pubmed: 16403930
Neurosurgery. 2007 Sep;61(3):644-50; discussion 650-1
pubmed: 17881980